Article
Genetic variants of organic cation transporter 1 (OCT1) and OCT2 significantly reduce lamivudine uptake.
Biopharmaceutics & drug disposition - 1 Apr 2012
Choi Min-Koo, Song Im-Sook
Abstract excerpt
The study sought to investigate the effect of genetic variants of OCT1 (OCT1-P283L and -P341L) and OCT2 (OCT2-T199I, -T201M and -A270S), which were identified in a Korean population, on the transport of lamivudine in vitro and to compare the substrate dependent effects of OCT1 and OCT2 variants with 1-methyl-4-phenylpyridinium (MPP+), tetraethyl ammonium (TEA), metformin and lamivudine as substrates for these...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
